🔎 Trials Near Me

Domov › Wilmsjev tumor › Kalifornija

Klinične študije za Wilmsjev tumor v Kalifornija

5 študij za Wilmsjev tumor išče udeležence na lokacijah v Kalifornija.

Mesta v Kalifornija

Uradno besedilo študije (angleško)

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

  • Children's Hospital Los Angeles, Los Angeles
  • Lucile Packard Children's Hospital Stanford University, Palo Alto
Vključevanje udeležencevFaza 2
Starost 12–39 · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT04616560

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

  • Kaiser Permanente Downey Medical Center, Downey
  • Loma Linda University Medical Center, Loma Linda
  • Miller Children's and Women's Hospital Long Beach, Long Beach
  • in še 11
Vključevanje udeležencevFaza 2
Do 30 let · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT04322318

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Children's Hospital Los Angeles, Los Angeles
  • Children's Hospital of Orange County, Orange
  • UCSF Medical Center-Mission Bay, San Francisco
Vključevanje udeležencevFaza 1/2
12 Months – 30 Years · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT04851119

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

  • Lucille Packard Children's Hospital Stanford, Palo Alto
Vključevanje udeležencevFaza 1/2
12 Months – 30 Years · Vsi spoli · Posodobljeno 19. maj 2026 · NCT04901702

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

  • Children's Hospital of Los Angeles (Data Collection Only), Los Angeles
  • Stanford Medicine Children's Health (Data Collection Only), Palo Alto
Vključevanje udeležencevFaza 2
12 Months · Vsi spoli · Posodobljeno 6. maj 2026 · NCT05985161

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.